Literature DB >> 24461717

Evaluation of full costs of care for patients with Alzheimer's disease in France: the predominant role of informal care.

Chloé Gervès1, Pauline Chauvin2, Martine Marie Bellanger3.   

Abstract

OBJECTIVE: It is crucial that the cost of Alzheimer's disease be evaluated, from a societal perspective, since the number of patients is expected to increase dramatically in the coming decades. This assessment of the full cost of care for community-dwelling patients with Alzheimer's disease in France also addresses the factors associated with informal care, its predominant component. DATA AND METHODS: From 2009 to 2010, 57 patient/informal caregiver pairs were interviewed using the Resource Utilization in Dementia questionnaire, adapted to provide a micro-costing approach of the overall care process. Both the opportunity cost method and the proxy good method were used to value informal care. Ordinary least square regression was performed to determine factors associated with informal care.
RESULTS: Average total monthly costs were €2450 with the proxy good method and €3102 with the opportunity cost method. Living with the patient, severity of dementia and hours spent on formal care were significantly associated with informal care time. POLICY IMPLICATIONS: Since French allowance cannot cover all formal and informal non-medical costs, the choice for policy makers is either to spend more on formal care or to develop family care by investing in supportive programmes for informal caregivers.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Formal care; France; Informal care; Opportunity cost method; Proxy good method

Mesh:

Year:  2014        PMID: 24461717     DOI: 10.1016/j.healthpol.2014.01.001

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  14 in total

1.  The economic burden of the care and treatment for people with Alzheimer's disease: the outlook for the Czech Republic.

Authors:  Petra Marešová; Veronika Zahálková
Journal:  Neurol Sci       Date:  2016-07-28       Impact factor: 3.307

2.  Classification tree model of the personal economic burden of dementia care by related factors of both people with dementia and caregivers in Japan: a cross-sectional online survey.

Authors:  Takayo Nakabe; Noriko Sasaki; Hironori Uematsu; Susumu Kunisawa; Anders Wimo; Yuichi Imanaka
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

Review 3.  The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review.

Authors:  Juan Oliva-Moreno; Marta Trapero-Bertran; Luz Maria Peña-Longobardo; Raúl Del Pozo-Rubio
Journal:  Pharmacoeconomics       Date:  2017-03       Impact factor: 4.981

4.  Economic Impact of Dementia by Disease Severity: Exploring the Relationship between Stage of Dementia and Cost of Care in Taiwan.

Authors:  Li-Jung Elizabeth Ku; Ming-Chyi Pai; Pei-Yu Shih
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

5.  How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study.

Authors:  Mark Belger; Josep Maria Haro; Catherine Reed; Michael Happich; Kristin Kahle-Wrobleski; Josep Maria Argimon; Giuseppe Bruno; Richard Dodel; Roy W Jones; Bruno Vellas; Anders Wimo
Journal:  BMC Med Res Methodol       Date:  2016-07-18       Impact factor: 4.615

6.  Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.

Authors:  Alan Lenox-Smith; Catherine Reed; Jeremie Lebrec; Mark Belger; Roy W Jones
Journal:  BMC Geriatr       Date:  2016-11-25       Impact factor: 3.921

7.  Monetary costs of Alzheimer's disease in China: protocol for a cluster-randomised observational study.

Authors:  Fangyu Li; Shuoqi Chen; Cuibai Wei; Jianping Jia
Journal:  BMC Neurol       Date:  2017-01-25       Impact factor: 2.474

8.  Early intervention in Alzheimer's disease: a health economic study of the effects of diagnostic timing.

Authors:  Jennifer H Barnett; Lily Lewis; Andrew D Blackwell; Matthew Taylor
Journal:  BMC Neurol       Date:  2014-05-07       Impact factor: 2.474

9.  The social and economic burden of frontotemporal degeneration.

Authors:  James E Galvin; David H Howard; Sharon S Denny; Susan Dickinson; Nadine Tatton
Journal:  Neurology       Date:  2017-10-04       Impact factor: 9.910

10.  The social and economic burden on family caregivers for older adults in the Czech Republic.

Authors:  Petra Maresova; Sunwoo Lee; Oluwaseun Omolaja Fadeyi; Kamil Kuca
Journal:  BMC Geriatr       Date:  2020-05-11       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.